Works matching IS 00070920 AND DT 2022 AND VI 126 AND IP 7

Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 7, p. 1082, doi. 10.1038/s41416-021-01670-w
    By:
    • Schack, Line M. H.;
    • Naderi, Elnaz;
    • Fachal, Laura;
    • Dorling, Leila;
    • Luccarini, Craig;
    • Dunning, Alison M.;
    • The Head and Neck Group of the Radiogenomics Consortium;
    • Barnett, Gill;
    • Barrera, Miguel Elías Aguado;
    • Burnet, Neil G.;
    • Calvo, Laura M.;
    • Diergaarde, Brenda;
    • Dudding, Tom;
    • Dunning, Alison;
    • Duprez, Fréderic;
    • Kerns, Sarah L.;
    • Kiang, Melvin C. L.;
    • Langendijk, Hans;
    • Mehanna, Hisham;
    • Ness, Andy
    Publication type:
    Article
    10

    Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 7, p. 1027, doi. 10.1038/s41416-021-01664-8
    By:
    • Konstantinopoulos, Panagiotis A.;
    • Cheng, Su-Chun;
    • Supko, Jeffrey G.;
    • Polak, Madeline;
    • Wahner-Hendrickson, Andrea E.;
    • Ivy, S. Percy;
    • Bowes, Brittany;
    • Sawyer, Hannah;
    • Basada, Patrice;
    • Hayes, Martin;
    • Curtis, Jennifer;
    • Horowitz, Neil;
    • Wright, Alexi A.;
    • Campos, Susana M.;
    • Ivanova, Elena V.;
    • Paweletz, Cloud P.;
    • Palakurthi, Sangeetha;
    • Liu, Joyce F.;
    • D'Andrea, Alan D.;
    • Gokhale, Prafulla C.
    Publication type:
    Article
    11

    Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC).

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 7, p. 1047, doi. 10.1038/s41416-021-01662-w
    By:
    • Fotopoulou, Christina;
    • Rockall, Andrea;
    • Lu, Haonan;
    • Lee, Philippa;
    • Avesani, Giacomo;
    • Russo, Luca;
    • Petta, Federica;
    • Ataseven, Beyhan;
    • Waltering, Kai-Uwe;
    • Koch, Jens Albrecht;
    • Crum, William R.;
    • Cunnea, Paula;
    • Heitz, Florian;
    • Harter, Philipp;
    • Aboagye, Eric O.;
    • du Bois, Andreas;
    • Prader, Sonia
    Publication type:
    Article
    12
    13

    First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 7, p. 1010, doi. 10.1038/s41416-021-01657-7
    By:
    • Robbrecht, Debbie;
    • Jungels, Christiane;
    • Sorensen, Morten Mau;
    • Spanggaard, Iben;
    • Eskens, Ferry;
    • Fretland, Signe Ø;
    • Guren, Tormod Kyrre;
    • Aftimos, Philippe;
    • Liberg, David;
    • Svedman, Christer;
    • Thorsson, Lars;
    • Steeghs, Neeltje;
    • Awada, Ahmad
    Publication type:
    Article
    14
    15
    16
    17